Insight Partners, a leading global venture capital and private equity firm, recently announced the completion of a $61 million Series B funding round for Diligent Robotics, a company that develops robots to assist healthcare professionals with tasks such as delivering supplies and disinfecting surfaces.
The funding round was led by Insight Partners, with participation from existing investors such as E14 Fund, Promus Ventures, and Next Coast Ventures. The funds will be used to expand the company’s product offerings, accelerate its growth, and further develop its technology.
Diligent Robotics was founded in 2018 by Andrea Thomaz and Vivian Chu, both of whom have extensive experience in the field of robotics. The company’s flagship product, Moxi, is a mobile robot that can perform a variety of tasks such as delivering supplies, retrieving equipment, and disinfecting surfaces.
Moxi is designed to work alongside human healthcare professionals, assisting them with routine tasks so that they can focus on more complex and specialized work. The robot is equipped with sensors and cameras that allow it to navigate its environment and interact with people in a safe and efficient manner.
The COVID-19 pandemic has highlighted the importance of robotics in healthcare, and Diligent Robotics is well-positioned to capitalize on this trend. The company’s robots can help to reduce the risk of infection by handling tasks such as delivering supplies and disinfecting surfaces, which can help to minimize the exposure of healthcare professionals to the virus.
Diligent Robotics has already deployed its robots in a number of hospitals and healthcare facilities, where they have been well-received by staff and patients alike. The company has also partnered with a number of leading healthcare organizations to further develop its technology and explore new use cases.
The recent funding round is a strong endorsement of Diligent Robotics’ vision and potential. The company is at the forefront of a rapidly growing industry, and its innovative approach to robotics in healthcare has the potential to transform the industry.
The funds will be used to expand the company’s product offerings, accelerate its growth, and further develop its technology. Diligent Robotics plans to expand its team, increase production of its robots, and develop new use cases for its technology.
The company is also focused on developing partnerships with leading healthcare organizations to further develop its technology and explore new use cases. By working closely with healthcare professionals, Diligent Robotics is able to ensure that its robots are meeting the needs of the industry and providing real value to healthcare organizations.
The market for robotics in healthcare is expected to grow rapidly in the coming years, driven by a number of factors such as an aging population, rising healthcare costs, and the increasing demand for automation in healthcare. Diligent Robotics is well-positioned to capitalize on this trend, and its innovative approach to robotics in healthcare has the potential to transform the industry.
In addition to its focus on healthcare, Diligent Robotics is also active in the research community, publishing papers on a range of topics related to robotics and artificial intelligence. The company’s research has been well-received and has helped to establish it as a thought leader in the space.
In conclusion, Diligent Robotics’ $61 million Series B funding round is a strong endorsement of the company’s vision and potential. The company is at the forefront of a rapidly growing industry, and its innovative approach to robotics in healthcare has the potential to transform the industry. The funds will be used to expand the company’s product offerings, accelerate its growth, and further develop its technology. Diligent Robotics is a company to watch in the robotics and healthcare space, and its continued success will be an important indicator of the direction of the industry.